Pharma & Biotech
Pharma & Biotech
Director Interviews
OTC Markets
OTC Markets
Director Interviews
OTC Markets
OTC Markets
Director Interviews
Director Interviews
Small caps
Empower Clinics delivering essential medical cannabis treatment options to an increasing number of US patients
The firm is one of the largest operators of medical-cannabis-focused healthcare in the US
A pre-clinical mouse study last year of the drug also offered new insights into a potential...
Analyst Murray Gunn reckons the initial crash is “the first wave of a three-wave process”, which...
The US-listed Danish company is seeking FDA approval of the test for use in children and...
The Nevada-headquartered firm has nine assets in the cannabis industry, six of which it wholly owns
BioCorRx (OTCMKTS: BICX) CEO Brady Granier joined Steve Darling from Proactive in Vancouver to discuss if their business and research are being affected by the outbreak of COVID-19. Granier telling Proactive some of the ways the company is able to continue their works especially when it...
Pharma & Biotech
CytoDyn sees impressive results with Leronlimab on very ill...
Pharma & Biotech
Full interview: Algernon Pharmaceuticals updates Phase 2 human...
Medical technology & services
NanoViricides continuing their work to find a treatment for COVID-19
Retail & consumer
Market Report
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
